Previous Article | Next Article 
Molecular and Cellular Biology, February 2003, p. 777-790, Vol. 23, No. 3
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.3.777-790.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation
Martin Leverkus,1* Martin R. Sprick,2 Tina Wachter,1 Thilo Mengling,1 Bernd Baumann,3 Edgar Serfling,4 Eva-B. Bröcker,1 Matthias Goebeler,1 Manfred Neumann,4 and Henning Walczak2
Department of Dermatology,1
Institute of Pathology, University of Würzburg Medical School, 97080 Würzburg,4
Division of Apoptosis Regulation, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg,2
Department of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany3
Received 22 May 2002/
Returned for modification 18 July 2002/
Accepted 6 November 2002
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) exerts potent cytotoxic activity against transformed keratinocytes, whereas primary keratinocytes are relatively resistant. In several cell types, inhibition of the proteasome sensitizes for TRAIL-induced apoptosis by interference with NF-
B activation. Here we describe a novel intracellular mechanism of TRAIL resistance in primary cells and how this resistance is removed by proteasome inhibitors independent of NF-
B in primary human keratinocytes. This sensitization was not mediated at the receptor-proximal level of TRAIL DISC formation or caspase 8 activation but further downstream. Activation of caspase 3 was critical, as it only occurred when mitochondrial apoptotic pathways were activated, as reflected by Smac/DIABLO, HtrA2, and cytochrome c release. Smac/DIABLO and HtrA2 are needed to release the X-linked inhibitor-of-apoptosis protein (XIAP)-mediated block of full caspase 3 maturation. XIAP can effectively block caspase 3 maturation and, intriguingly, is highly expressed in primary but not in transformed keratinocytes. Ectopic XIAP expression in transformed keratinocytes resulted in increased resistance to TRAIL. Our data suggest that breaking of this resistance via proteasome inhibitors, which are potential anticancer drugs, may sensitize certain primary cells to TRAIL-induced apoptosis and could thereby complicate the clinical applicability of a combination of TRAIL receptor agonists with proteasome inhibitors.
* Corresponding author. Mailing address: Department of Dermatology, University of Würzburg Medical School, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. Phone: 49 931 201 26356. Fax: 49 931 201 26700. E-mail:
leverkus_m{at}klinik.uni-wuerzburg.de.
This article is dedicated to Harald zur Hansen on the occasion of his retirement as head of the German Cancer Research Center (Deutsches Krebs forschungszentrum) in Heidelberg with gratitude and appreciation for 20 years of leadership.
Molecular and Cellular Biology, February 2003, p. 777-790, Vol. 23, No. 3
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.3.777-790.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Pandey, A. K., Sodhi, A.
(2009). Recombinant YopJ induces apoptosis in murine peritoneal macrophages in vitro: involvement of mitochondrial death pathway. Int Immunol
21: 1239-1249
[Abstract]
[Full Text]
-
IIJIMA, M., MOMOSE, I., IKEDA, D.
(2009). TP-110, a New Proteasome Inhibitor, Down-regulates IAPs in Human Multiple Myeloma Cells. Anticancer Res
29: 977-985
[Abstract]
[Full Text]
-
Shanker, A., Brooks, A. D., Tristan, C. A., Wine, J. W., Elliott, P. J., Yagita, H., Takeda, K., Smyth, M. J., Murphy, W. J., Sayers, T. J.
(2008). Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody. JNCI J Natl Cancer Inst
100: 649-662
[Abstract]
[Full Text]
-
Baritaki, S., Suzuki, E., Umezawa, K., Spandidos, D. A., Berenson, J., Daniels, T. R., Penichet, M. L., Jazirehi, A. R., Palladino, M., Bonavida, B.
(2008). Inhibition of Yin Yang 1-Dependent Repressor Activity of DR5 Transcription and Expression by the Novel Proteasome Inhibitor NPI-0052 Contributes to its TRAIL-Enhanced Apoptosis in Cancer Cells. J. Immunol.
180: 6199-6210
[Abstract]
[Full Text]
-
Li, W., Zhang, X., Olumi, A. F.
(2007). MG-132 Sensitizes TRAIL-Resistant Prostate Cancer Cells by Activating c-Fos/c-Jun Heterodimers and Repressing c-FLIP(L). Cancer Res.
67: 2247-2255
[Abstract]
[Full Text]
-
Ceruti, S., Mazzola, A., Abbracchio, M. P.
(2006). Proteasome Inhibitors Potentiate Etoposide-Induced Cell Death in Human Astrocytoma Cells Bearing a Mutated p53 Isoform. J. Pharmacol. Exp. Ther.
319: 1424-1434
[Abstract]
[Full Text]
-
Kerstan, A., Armbruster, N., Leverkus, M., Hunig, T.
(2006). Cyclosporin A Abolishes CD28-Mediated Resistance to CD95-Induced Apoptosis via Superinduction of Caspase-3. J. Immunol.
177: 7689-7697
[Abstract]
[Full Text]
-
Braeuer, S. J., Buneker, C., Mohr, A., Zwacka, R. M.
(2006). Constitutively Activated Nuclear Factor-{kappa}B, but not Induced NF-{kappa}B, Leads to TRAIL Resistance by Up-Regulation of X-Linked Inhibitor of Apoptosis Protein in Human Cancer Cells. Mol Cancer Res
4: 715-728
[Abstract]
[Full Text]
-
Lane, D., Cote, M., Grondin, R., Couture, M.-C., Piche, A.
(2006). Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3.. Molecular Cancer Therapeutics
5: 509-521
[Abstract]
[Full Text]
-
Shi, R.-X., Ong, C.-N., Shen, H.-M.
(2005). Protein Kinase C Inhibition and X-Linked Inhibitor of Apoptosis Protein Degradation Contribute to the Sensitization Effect of Luteolin on Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Cancer Cells. Cancer Res.
65: 7815-7823
[Abstract]
[Full Text]
-
Siegmund, D., Wicovsky, A., Schmitz, I., Schulze-Osthoff, K., Kreuz, S., Leverkus, M., Dittrich-Breiholz, O., Kracht, M., Wajant, H.
(2005). Death Receptor-Induced Signaling Pathways Are Differentially Regulated by Gamma Interferon Upstream of Caspase 8 Processing. Mol. Cell. Biol.
25: 6363-6379
[Abstract]
[Full Text]
-
Nencioni, A., Wille, L., Dal Bello, G., Boy, D., Cirmena, G., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A.
(2005). Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells. Clin. Cancer Res.
11: 4259-4265
[Abstract]
[Full Text]
-
Nencioni, A., Hua, F., Dillon, C. P., Yokoo, R., Scheiermann, C., Cardone, M. H., Barbieri, E., Rocco, I., Garuti, A., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A.
(2005). Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood
105: 3255-3262
[Abstract]
[Full Text]
-
Shao, R., Lee, D.-F., Wen, Y., Ding, Y., Xia, W., Ping, B., Yagita, H., Spohn, B., Hung, M.-C.
(2005). E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation. Mol Cancer Res
3: 219-226
[Abstract]
[Full Text]
-
Boya, P., Gonzalez-Polo, R.-A., Casares, N., Perfettini, J.-L., Dessen, P., Larochette, N., Metivier, D., Meley, D., Souquere, S., Yoshimori, T., Pierron, G., Codogno, P., Kroemer, G.
(2005). Inhibition of Macroautophagy Triggers Apoptosis. Mol. Cell. Biol.
25: 1025-1040
[Abstract]
[Full Text]
-
Wachter, T., Sprick, M., Hausmann, D., Kerstan, A., McPherson, K., Stassi, G., Brocker, E.-B., Walczak, H., Leverkus, M.
(2004). cFLIPL Inhibits Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated NF-{kappa}B Activation at the Death-inducing Signaling Complex in Human Keratinocytes. J. Biol. Chem.
279: 52824-52834
[Abstract]
[Full Text]
-
Marconi, A., Atzei, P., Panza, C., Fila, C., Tiberio, R., Truzzi, F., Wachter, T., Leverkus, M., Pincelli, C.
(2004). FLICE/caspase-8 activation triggers anoikis induced by {beta}1-integrin blockade in human keratinocytes. J. Cell Sci.
117: 5815-5823
[Abstract]
[Full Text]
-
Wilkinson, J. C., Cepero, E., Boise, L. H., Duckett, C. S.
(2004). Upstream Regulatory Role for XIAP in Receptor-Mediated Apoptosis. Mol. Cell. Biol.
24: 7003-7014
[Abstract]
[Full Text]
-
Leverkus, M., McLellan, A. D., Heldmann, M., Eggert, A. O., Brocker, E.-B., Koch, N., Kampgen, E.
(2003). MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int Immunol
15: 993-1006
[Abstract]
[Full Text]
-
Wajant, H.
(2003). Targeting the FLICE Inhibitory Protein (FLIP) in Cancer Therapy. Mol. Interv.
3: 124-127
[Abstract]
[Full Text]